The World Health Organization (WHO) has developed a prognostic scoring system for Gestational trophoblastic disease (GTD), which correlates with patient prognosis.
Prognostic Factor |
Finding |
Points |
---|---|---|
age in years |
<= 39 |
0 |
|
> 39 |
1 |
antecedent pregnancy |
hydatidiform mole |
0 |
|
abortion or ectopic |
1 |
|
term pregnancy |
2 |
interval in months between end of antecedent pregnancy & start of chemotherapy |
< 4 |
0 |
|
4 - 6 |
1 |
|
7 - 12 |
2 |
|
> 12 |
4 |
beta-HCG in IU/L |
< 1,000 |
0 |
|
1,000 - 10,000 |
1 |
|
10,000 - 100,000 |
2 |
|
> 100,000 |
4 |
ABO blood group |
patient O & partner A; patient A & partner O |
1 |
|
patient B or AB |
2 |
largest tumor, including uterine tumor |
< 3 cm |
0 |
|
3 - 5 cm |
1 |
|
> 5 cm |
2 |
site of metastases |
none, or other sites |
0 |
|
spleen, kidney |
1 |
|
GI tract, liver |
2 |
|
brain |
4 |
number of metastases |
none |
0 |
|
1 - 4 |
1 |
|
4 - 8 |
2 |
|
> 8 |
4 |
prior chemotherapy |
none |
0 |
|
single drug |
2 |
|
2+ drugs |
4 |
WHO prognostic index score =
= SUM (prognostic factor scores)
Interpretation:
• minimum score 0
• maximum score 27
• low risk: 0 - 4
• intermediate risk: 5 - 7
• high risk: >= 8
Purpose: To predict the prognosis for a patient with gestational trophoblastic disease (GTD) using an index developed by the WHO.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
Objective: severity, prognosis, stage
ICD-10: C58,